School of Medicine


Showing 11-20 of 126 Results

  • Paul Cheng MD PhD

    Paul Cheng MD PhD

    Assistant Professor of Medicine (Cardiovascular Medicine)

    BioDr. Cheng is a Cardiologist at Stanford University School of Medicine in the Department of Medicine and a member of the Cardiovascular Research Institute. Dr. Cheng received his BEng in Chemical Engineering and BSc in biology at MIT. He subsequently completed his MD/PhD at UCSF working in the Srivastava lab studying how extracellular morphogenic signals affect cardiac development and fate determination of cardiac progenitors. Dr. Cheng completed internal medicine residency and cardiology fellowship at Stanford. His current clinical focus is in amyloidosis and cardio-oncology. During his post doctoral research in the Quertermous lab, he pioneered the application of single cell transcriptomic and epigenetic techniques to study human vascular diseases including atherosclerosis and aneurysm, and applied these techniques to investigate molecular mechanisms behind genetic risk factors for several human vascular diseases including atherosclerosis, and aortopathies such as Marfan's and Loey-Dietz syndrome.

    The Cheng lab takes a patient-to-bench-to-bedside approach to science. The lab focuses on elucidating new pathogenic mechanisms of human vascular diseases through combing human genetics and primary vascular disease tissues, with high-resolution transcriptomic and epigenetic profiling to generate novel hypothesis that are then tested in a variety of in vitro and in vivo models. The lab is focused on two broad questions: (1) understanding the biological underpinning of the differences in diseases propensities of different arterial segments in an individual (i.e. why do you have atherosclerosis and aneurysms in certain segments but not others), and (2) understanding the role of perivascular fibroblast in human vascular diseases.

    Find out more about what the Cheng lab is up to, check out https://chenglab.stanford.edu

  • Daniel Clark, MD, MPH

    Daniel Clark, MD, MPH

    Clinical Assistant Professor, Medicine - Cardiovascular Medicine
    Clinical Assistant Professor, Pediatrics - Cardiology

    BioDr. Clark is a board-certified, fellowship-trained cardiologist with the Adult Congenital Heart Program at Stanford Health Care. He is also a clinical assistant professor with dual appointments in the Division of Cardiovascular Medicine, Department of Medicine and the Division of Cardiology, Department of Pediatrics at Stanford University School of Medicine.

    Dr. Clark specializes in the diagnosis and treatment of adult congenital heart disease (ACHD) and the management of congenital and acquired heart disease in children. His clinical focus involves the combined use of cardiac magnetic resonance (CMR) and other imaging techniques to evaluate patients with known or suspected cardiovascular disease. Dr. Clark’s extensive training and experience with these techniques include multiple fellowships in adult cardiology, cardiovascular imaging, and ACHD.

    Dr. Clark is currently a co-investigator on multiple research studies. During his fellowship, he received a training grant from the National Institutes of Health enabling evaluation of the ability of CMR to diagnose COVID-19-associated heart inflammation among college athletes. He currently uses CMR to assess heart transplant outcomes in donors positive for hepatitis C virus. Dr. Clark also received a research grant from the Adult Congenital Heart Disease Association supporting a randomized, controlled clinical trial of cardiac rehabilitation among patients with Fontan failure.

    Dr. Clark serves as a peer reviewer for multiple prestigious journals, including The New England Journal of Medicine, Circulation, Journal of the American College of Cardiology, and Journal of the American Heart Association (JAHA). He serves on the editorial board for both JAHA and Circulation: Cardiovascular Imaging. He is also a member of numerous professional medical societies, including the American College of Cardiology, the American Heart Association, and the Adult Congenital Heart Association.

  • William Clusin, MD

    William Clusin, MD

    Associate Professor of Medicine (Cardiovascular Medicine)

    Current Research and Scholarly InterestsCardiac action potentials; tissue culture, voltage, clamp technique; role of calcium in ischemia arrhythmias; coronary, artery disease; myocardial infarction.

  • John P. Cooke, MD, PhD

    John P. Cooke, MD, PhD

    Professor of Medicine (Cardiovascular Medicine), Emeritus

    Current Research and Scholarly InterestsOur translational research program in vascular regeneration is focused on generating and characterizing vascular cells from human induced pluripotential stem cells. We are also studying the therapeutic application of these cells in murine models of peripheral arterial disease. In these studies we leverage our longstanding interest in endothelial signaling, eg by nitric oxide synthase (NOS) as well as by nicotinic cholinergic receptors (nAChR).

  • Rajesh Dash, MD PhD;      Director of SSATHI & CardioClick

    Rajesh Dash, MD PhD; Director of SSATHI & CardioClick

    Associate Professor of Medicine (Cardiovascular Medicine)

    Current Research and Scholarly InterestsI have two research areas:
    1) Heart disease in South Asians - genetic, metabolic, & behavioral underpinnings of an aggressive phenotype.

    2) Imaging cell injury & recovery in the heart. Using Cardiac MRI to visualize signals of early injury and facilitating preventive medical therapy. Optimizing new imaging methods for viable cells to delineate live heart cells or transplanted stem cells.

  • Colette DeJong

    Colette DeJong

    Clinical Instructor, Medicine - Cardiovascular Medicine

    BioDr. Colette DeJong is general cardiologist and health services researcher at Stanford University and the VA Palo Alto. A graduate of Brown University and the University of California, San Francisco School of Medicine, Dr. DeJong completed an internal medicine residency, chief residency, and fellowship in cardiovascular medicine at UCSF, as well as a two-year editorial fellowship at JAMA Internal Medicine and a research fellowship at the UCSF Center for Healthcare Value. Dr. DeJong’s research focuses on improving access to effective cardiovascular therapies. She is interested in developing and evaluating novel strategies to improve care delivery, such as cardiovascular combination pills (“polypills”). Dr. DeJong served as the principal investigator of a pilot clinical trial of heart failure polypills at Zuckerberg San Francisco General Hospital.

  • Timothy Joseph Devine

    Timothy Joseph Devine

    Clinical Assistant Professor, Medicine - Cardiovascular Medicine

    BioTimothy Devine is a board-certified cardiologist at Stanford Health Care and a clinical assistant professor in the Division of Cardiovascular Medicine at Stanford University School of Medicine. In 2024, he joined the Stanford family from San Bernardino County Kaiser, where he practiced since 2011. Born and raised in the Philadelphia area, he relocated to California in 2001 to complete his Naval Residency in San Diego and later his General Cardiology Fellowship at Scripps Clinic with an associate fellowship in Integrative Medicine. At Kaiser, he was instrumental in creating several innovative projects: Cardiology Hospitalist Program dedicated to resident teaching, “Doc of the Day” - a team-based digital platform that proactively manages urgent outpatient cardiac issues, and a Cardiac Point-of-Care Ultrasound program. He is passionate about medical education, specifically teaching the art of medicine. For research, he hopes to explore ways to improve the healthcare delivery system to efficiently move people from patienthood to health. Personally, you may catch him exploring the Bay Area by bike, boat, or BART as he is eager to meet others for recreational or service opportunities to improve the health of our community.